Abstract
The microbiology of infective endocarditis (IE) has evolved significantly over the last century. Previously a community-acquired disease affecting predominantly patients with rheumatic heart disease, IE is now being seen in new populations including IV drug users, patients with prosthetic valves, and patients infected through healthcare associated bacteremia. Improved blood culture technologies and non-culture laboratory methods have also resulted in a lower rate of culture-negative cases. Because of differing proportions of particular risk groups, the etiologic agents responsible for causing infective endocarditis vary significantly among continents, countries, regions within countries and even between different years in an individual hospital.
Blood culture remains the single most important investigation in a patient suspected of having infective endocarditis. If appropriately collected prior to antibiotic administration, blood cultures can be expected to yield growth of the causative organism in over 90 % of cases of infective endocarditis. Serologic testing can be useful in determining the cause of IE in true culture-negative cases, which are usually caused by organisms that are difficult to culture including Coxiella burnetti, Bartonella spp., Chlamydia spp. and Legionella species. In spite of limitations including the potential presence of PCR inhibitors in clinical samples and the possibility of sample to sample contamination, molecular amplification methods can be useful in establishing the cause of IE. To date, PCR methods have been applied with most success to surgically excised valve tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin N Am. 2002;16(2):255–72, vii.
Murdoch DR, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169(5):463–73.
Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345(18):1318–30.
Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139–49.
Slipczuk L, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. doi:10.1371/journal.pone.0082665.
Tleyjeh IM, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County Minnesota. JAMA. 2005;293(24):3022–8.
Tleyjeh IM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025–35.
Miro JM, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41(4):507–14.
Fowler Jr VG, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012–21.
Federspiel JJ, et al. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med. 2012;172(4):363–5.
Hill EE, et al. Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:445–50.
Bor DH, et al. Infective endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One. 2013;8(3):e60033. doi:10.1271/journal.pone.0060033.
Chu VH, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2004;39(10):1527–30.
Chu VH, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46:232–42.
Chu VH, et al. Coagulase-negative staphyloccal prosthetic valve endocarditis – a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart. 2009;95:570–6.
Seenivasan MH, Yu VL. Staphylococcus lugdunensis endocarditis – the hidden peril of coagulase-negative staphylococcus in blood cultures. Eur J Clin Microbiol Infect Dis. 2003;22(8):489–91.
Baddour LM, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association – executive summary: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):3167–84.
Hoen B, et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis. 2005;24(1):12–6.
Lindberg J, et al. Incidence of pneumococcal endocarditis: a regional health register-based study in Denmark 1981–1996. Scand J Infect Dis. 2005;37(6–7):417–21.
Fernandez-Guerrero ML, et al. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med. 2002;252(6):510–5.
Mandell GL. Enterococcal endocarditis: an analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med. 1970;125(2):258–64.
McDonald JR, et al. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med. 2005;118(7):759–66.
Chirouze C, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis – prospective cohort study. Clin Microbiol Infect. 2013;19:1140–7.
Chamber ST, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8(5):e63181. doi:10.1371/journal.pone.0063181.
Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin N Am. 2002;16(2):477–505.
Wang A, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354–61.
Rivas P, et al. The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis. Chest. 2005;128(2):764–71.
Brown PD, Levine DP. Infective endocarditis in the injection drug user. Infect Dis Clin N Am. 2002;16(3):645–65, viii-ix.
Mathew J, et al. Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis. Angiology. 2001;52(12):801–9.
Miro JM, et al. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am. 1997;16(2):273–95.
Saydain GM, et al. Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit. J Crit Care. 2010;25:248–53.
Komshian SV, et al. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis. 1990;12(4):693–702.
Mills J, Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med. 1976;84(1):29–35.
Van Scoy RE. Culture-negative endocarditis. Mayo Clin Proc. 1982;57(3):149–54.
Bouza E, et al. Infective endocarditis – a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80(5):298–307.
Werner M, et al. A clinical study of culture-negative endocarditis. Medicine (Baltimore). 2003;82(4):263–73.
Zamorano J, et al. Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment. J Heart Valve Dis. 2003;12(2):256–60.
Madico GE, Rice PA. 16s-Ribosomal DNA to diagnose culture-negative endocarditis. Curr Infect Dis Rep. 2008;10:280–6.
Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84(3):162–73.
Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177–207.
Casalta JP, et al. Prevalence of Coxiella burnetii and Bartonella species as cases of infective endocarditis in Marseilles (1994–2007). Eur Soc Clin Microbiol Infect Dis. 2009;15 Suppl 2:152–3.
Fournier PE, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore). 2001;80(4):245–51.
Fenollar F, Lepidi H, Raoult D. Whipple’s endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis. 2001;33(8):1309–16.
Geissdörfer W, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216–22.
Rognon R, Kehtari R, Francioli P. Individual value of each of the Duke criteria for the diagnosis of infective endocarditis. Clin Microbiol Infect. 1999;5(7):396–403.
Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol. 1994;32(11):2829–31.
Towns ML, Reller LB. Diagnostic methods current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. Infect Dis Clin N Am. 2002;16(2):363–76, ix-x.
Houpikian P, Raoult D. Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Infect Dis Clin N Am. 2002;16(2):377–92, x.
Gauduchon V, et al. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol. 2003;41(2):763–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing
About this chapter
Cite this chapter
Skinner, S., Wudel, B., Sanche, S.E. (2016). Microbiology of Infective Endocarditis and Microbiologic Diagnosis. In: Chan, KL., Embil, J. (eds) Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-27784-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-27784-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27782-0
Online ISBN: 978-3-319-27784-4
eBook Packages: MedicineMedicine (R0)